Hot Investor Mandate 2: Corporate VC Seeks Digital Medicine Devices and Wearables in Chronic Care

29 Sep

A pharma firm established a new corporate venture arm in 2015.  The firm is based in London and invests from a $30M fund, typically contributing $250K-$3M to a finacing round. The firm will participate in rounds for digital health companies at all stages, as early as seed and through later venture rounds. They are open to working with companies globally, but focus on US-based investments.

Within digital health, the firm is seeking digital medicine devices and wearables that address chronic or respiratory diseases, oncology, and consumer health. Past investments in the space include a wearable nicotine delivery device with integrated software and data analytics component to aid in smoking cessation.

The firm prefers to work with full management teams with a track record in the space. A strong business plan should be in place, and companies should have IP around their products.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: